Ryman Healthcare's sales rebound, guidance beat expected after Q2 surge

Ryman Healthcare recorded 367 occupation right agreement (ORA) sales in Q2 FY26, comprising 93 new sales and 274 resales, marking a 9% increase from Q1 FY26 and the second consecutive quarterly rise. Total sales for the first half of FY26 reached 704, tracking ahead of the previous guidance range of 1,100–1,300 ORA sales for the full year. An updated guidance range is anticipated on 27 November 2025.

The improved sales performance was attributed to enhanced sales effectiveness, strong conversion rates, and robust lead generation. Occupancy in mature aged care centers stood at 95.8% in Q2 FY26. The company also noted a significant uplift in the average deferred management fee, rising by nearly 40% due to a new standard pricing model.

Despite the positive quarterly growth, Q2 FY26 volumes were 18% lower than the record Q2 FY25. Ryman Healthcare is actively managing its aged care capacity, including the closure of two rest-home-level-only care centers in Christchurch.